Safety and Tolerability Study for Age-Related Macular Degeneration

Clinical trial NCT01485588 · COMPLETED

Trial details

NCT number: NCT01485588
Sponsor: Iconic Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neovascular Age-Related Macular Degeneration

Start date: 2010-12-01
Primary completion: 2012-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.